Amcor's Inflection: Volume Turns Positive, Synergies Run Ahead, and Deleveraging Gets a Path
After a two-year volume grind and the Berry integration, Amcor posts an inflection quarter — modestly positive volumes, $115M in quarterly synergies, and a transition-period guide pointing at double-digit CY2027 EPS growth.
AMCR · Earnings Call · 2026-08-12
The Turning Point
Amcor’s fiscal 2026 fourth quarter was the moment the “integrate-then-grow” plan started showing up in the operating numbers. After quarters of grinding volume declines — down 1.5% in Q3, low single digits through much of the year — the company reported volume growth turning modestly positive in Q4, with sequential improvement of about 200 basis points. CEO Peter Konieczny framed it as an inflection:The macro backdrop was hardly cooperative. The Middle East conflict spiked input costs, and CFO Steve Scherger noted on the call that the quarter saw $280M of price realization, essentially matching the inflation that hit the business. That price-cost relationship held — a direct product of the pass-through mechanisms Amcor built during the 2022-23 inflation cycle, which the company now applies across the combined legacy-Berry portfolio.We were pleased to see an inflection to modestly positive volume growth in the quarter. Sequentially, volume increased approximately 200 basis points with growth across several market categories.
Synergies and Green Shoots
The more structural story is synergy capture. FY2026 delivered $285M of synergies — roughly 10% ahead of the initial year-1 target — with Q4 alone contributing $115M. Say it plainly: this is the fulcrum on which the whole investment case turns. The $650M three-year target remains intact, and about half of the growth-synergy goal was already secured — roughly $140M of annualized new business awards against a $280M three-year target. PK is explicit that the pipeline is still building: “synergy capture exceeded our expectations during the quarter as we realized $115 million of synergy... approximately 10% ahead of our initial year 1 expectations.” — Peter Konieczny, Chief Executive Officer · 2026-08-12 The tone shift is visible in the keywords. Green shoots is a genuinely new phrase for this company — it replaces the defensive “cost-out” language that dominated 2025 and early 2026 calls. PK used it to describe foodservice, pet care and protein, categories where the combined company is gaining share through the Moda acquisition and broader product reach. CFO Steve Scherger added that July volumes were “consistent with Q4” — evidence the inflection is more than a one-quarter event.The Middle East Overhang
The other dominant theme of the call was cash. FY2026 free cash flow came in at $1.3B, about $200M below the outlook range, driven largely by working capital tied to the Middle East conflict. That's a notable reversal from the May call, where PK downplayed the conflict's impact: “We have no operations in the Middle East nor do we have any employees... we actually source very little resin from that region.” — Peter Konieczny, Chief Executive Officer · 2026-05-06 The reality in Q4 was that global input-cost contagion hit anyway, but the company was able to pass it through. Now the focus is on recovering the cash impact. Scherger said, “We expect to get the $500 million back over the next 12 months.” — Stephen Scherger, Chief Financial Officer · 2026-08-12 That recovery — plus continued EBITDA growth and portfolio divestiture proceeds — is the path from ~3.5x leverage down to ~3x by the end of CY2027.The balance sheet is the key constraint. Effective net cash sits at -$13.6B, and interest coverage is down to ~2.7x. This is a leveraged balance-sheet story now, and the market is betting the operating recovery outruns the debt drag.It's the kind of things you would expect from us. We've got very specific goals for days of inventory that we're carrying... specific targets for our days sales outstanding and then a continued positive march on increases in days payables.